30+ years of international IP experience across life sciences.
Strategic IP leadership for emerging life science companies.
LifeSci-IP helps life science organizations protect innovation, reduce IP risk and align patent strategy with business objectives. Led by Brad Salcedo, Esq., the firm provides fractional IP attorney and advisor support for patent portfolios, invention capture, FTO, due diligence, agreements and value creation. Whether you are building a first portfolio or preparing for a transaction, the work stays practical: IP decisions that move the business forward, not paperwork.
Govern patent portfolios with a filing strategy aligned to product pipelines, R&D direction and commercial priorities.
Lead practical invention mining and internal innovation capture programs that identify high-value discoveries early and clearly.
Support product launches and leadership decisions with FTO analysis, IP risk reporting and competitive patent landscape monitoring.
Prepare IP for partnerships, licensing, financing and acquisitions through focused due diligence and portfolio clean-up.
Support post-acquisition integration, spin-out structuring, IP separation and alliance management that protects shared value.
Review IP-intensive commercial and collaboration agreements to protect long-term value while keeping business objectives clear.
Brad Salcedo, Esq. brings more than 30 years of international experience across the US, UK, UAE and Europe. As founder of LifeSci-IP and a fractional IP attorney and advisor, he has supported industry leaders including Ipsen Pharmaceuticals, bioMérieux, Syngenta and Medtronic (Tyco/Covidien). His work focuses on managing patent portfolios with speed, precision and clear alignment to business objectives, so intellectual property becomes a strategic asset rather than a disconnected legal file.
His work sits at the intersection of science, strategy and execution. LifeSci-IP supports life science organizations as they protect innovation, mitigate risk, strengthen competitive position and make better decisions in fast-moving markets.
Built for life science companies that need experienced IP leadership without adding avoidable complexity.
The goal is simple: protect what matters, reduce risk where it counts, and turn IP into practical business value.
LifeSci-IP exists to help life science companies treat intellectual property as a business-critical asset. The work connects patent portfolio governance, invention capture, market exclusivity planning, FTO, risk reporting, due diligence and post-transaction integration into clear, usable decisions for leadership teams.
Whether you are shaping an R&D pipeline, preparing for financing, reviewing a collaboration, or integrating acquired IP, the support is practical, precise and aligned with the business.
Years international IP
Global markets noted
Strategic Asset
